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 The aim of the study was to develop and validate high performance liquid 
chromatography (HPLC) assay for the simultaneous determination of 
Metamizole, Thiamine and Pyridoxin in multicomponent tablet dosage 
form. The experimental procedure involved reversed-phase-HPLC with a 
Atlantis T3 C18 
column (5 μm particle size, 4.6 ID x 150 mm), PIC solution-
metanol-acetic acid volumetric  solution (700: 300 : 4, v/v/v) mobile phase, 
UV detection at 275 nm. The flow rate of the mobile phase was 1.2 mL/min. 
The method was validated with respect to specificity,  precision, accuracy  
and linearity. Due to its simplicity and accuracy, the assay method is suitable 
for routine analysis of multiomponen tablet formulation.  
 




Metamizole (MET), Thiamine (B1) and Pyridoxin (B6) 
are active pharmaceutical ingredients frequently 
combined and widely used to relieve pain complaints 
caused by neuritis and neuralgia, especially on severe 
pain (Indonesian Pharmacist Association, 2013). MET is 
pirazolon derivative having analgesic and antipiretic 
effects. It is commonly used to relieve acute pain 
(Zukowski and Kotfis, 2009). Thiamine and Pyridoxin are 
neurotropic vitamins which play an important role in 
formation of energy metabolism needed by brain cells. 
The combination of MET with vitamin B complex (ie. 
thiamine and pyridoxin) will increase the potential 
synergistic analgesic effect (Rosales et al., 2006). The 
chemical structure of MET, B1 and B6 are shown in Fig1. 
Some analytical methods have been reported for 
determination of MET, B1 and B6, either alone or in 
combination with other medicines in pharmaceutical 
products. Several analytical methods for determination 
MET such as electrochemical and electrophoretic 
(Basaez et al., 2008), reflectometric (Weinert et al., 
2007), spectrophotometry (Salih and Al-Sharook, 2008), 
HPLC (Altun, 2002) and LC/MS for bioequivalence study  
   




Fig 1. The chemical structure of  Metamizol, Thiamine1 and 
Pyridoxin 
 
(Shep et al., 2012). Furthermore several analytical 
methods of quantification B1 and B6 such as 
densitometry and spectrophotometry multivariat 
(Elzanfaly et al., 2010), capilary zone electrophoresis 
(Franco et al., 2012), HPLC (Yantih, et al., 2011; USP, 2013) 
and LC/MS (Chen, et al., 2006). The combination of MET, 
B1 and B6 is commercially available in tablet dosage form 
and most of the drugs in multicomponent dosage forms 
can be analyzed by HPLC.  
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The objective of this study was to develop and 
validate a specific, accurate, precise HPLC method for 
simultaneous determination MET, B1 and B6 in 
multicomponent tablet dosage form.  
 
2. Material and method 
2.1. Material 
The standards of MET, B1 dan B6 were of reference 
standard of Indonesian Pharmacopeia and were 
obtained from the National Agency of Drug and Food 
Control, Republic of Indonesia. The chemicals and 
reagents used were analytical grade. Methanol (HPLC 
grade, Merck), pentan sulphonic acid sodium salt 
(Merck), heptan sulphonic acid sodium salt (Merck), 
acetic acid (Merck) and bi-distillated water 
(Ikapharmindo) were used to prepare the dilute solution 
and mobile phase.  
The tablet dosage form was obtained from 
pharmacy in Yogyakarta, labeled to contain 500 mg, 50 
mg, 100 mg and 100 µg of MET, B1, B6 and B12 respectively 
in each tablet. 
 
2.2. Aparatus 
The method development was performed with a LC 
system consisting of Shimadzu LC 20AD solvent delivery 
system, a SPD-M20A photo diode array detector and 
samples were injected with a 7725i Rheodyne injector 
system with a 20 µL sample loop. The assay were 
performed with another LC system consisting of 
Shimadzu LC 20 AD solvent delivery system, SPD 20A 
uv/vis detector and SIL 20A autosampler using 20 μL 
sample loop. The detector was set at 275 nm. 
Separation was carried out at ambient temperature 
using an Atlantis T3 C18 colomn (5μm, 150 x 4,6 mm I.D., 
Waters, Milford, USA). All the calculations of 
quantitative analysis were performed with external 
standarization by the measurement of peak area. 
 
2.3. Method 
2.3.1. Preparation dilute solution 
Dilute solution were 0,5% acetic acid in water 
 
2.3.2. Preparation of mobile phase 
Prepare PIC solution by dissolving a mixture of 
0.522 g pentane sulphonic acid sodium salt and 0.404 g 
heptane sulphonic acid sodium salt into bi-destilated 
water. 
A mixture of PIC solution-Methanol-Acetic acid 
glacial (700:300:4) (v/v/v) was used for mobile phase. 
The mobile phase were filtered through a 0.45 µm 
milipore filter before use and degassed in an ultrasonic 
bath.  
 
2.3.3.Standart stock solution and sample stock solution 
Standard stock solution composed of a mixture of 
400 µg/mL MET, 40 µg/mL B1 and 80 µg/mL B6, while the 
stock sample solution made by dissolving the sample in 
order to obtain the composition of 1500 μg/mL MET, 150 
μg/mL B1 and 300 μg/mL B6) 
 
2.3.4.Working standart solution 
Working standard solution was made by dissolving 
standard stock solution to obtain 200 μg/mL MET, 20 
μg/mL B1 and 40 μg/mL B6. Six replicate of 20 μL injection 
were made for system suitability test. 
 
2.3.5.Sample solution preparation 
Sample solutions were made by weighing tablets 
that have been crushed an equivalent to 10 mg MET, 1 
mg B1 and 2 mg B6 in 50 mL volumetric flask and dilute 
with acetic acid 0.5%. Then, the solution was shaken 
vigorously for 30 minutes. The solution was filtered 
using Whatman microfilter Ø 0,45µm, and supernatant 
was taken. Standart and sample solution were subjected 
to HPLC measurement as describe above. The 
concentration of DIP, B1 and B6 in tablet dosage forms 
was calculated based on single point calibration. All 
determinations were performed six times. 
 
3. Result and Discusion 
Reference method of this study from NDFC 2001 
namely methampiron assay in a mixed multicomponent 
tablet. Flow rate between 1 mL/min and 1.2 mL/min were 
studied. A flow rate 1.2 mL/min chosen because it 
provides good separation in reasonable time. The 
separation of MET, B1 and B6 shown in figure 2.  
 
3.1. System Suitability Test (SST) 
The performance qualification of HPLC was 
determined with the system suitability to verify system 
performance under actual running conditions with a 
well-characterized analyte mixture, column, and mobile 
phase. The evaluation of SST based on the value of 
relative standart deviation (RSD) of peak area and 
retention time, and it performed every time when the 
analysis was began.  
The table 1 showed that RSD of  retention time and 
peak area MET, B1 and B6 were lower than 2%, that means 
performance of HPLC is good. 
 
3.2. Specificity 
ICH defines specificity as the ability to assess 
unequivocally the analyte in the presence of 
components which may be expected to be present. 
specificity determination can be done by calculating the 
resolution and peak purity index values obtained using 
the PDA detector (Snyder et al., 1997, Ahuja and Dong, 
2005).  
In this study, the resolution of MET, B1 and B6 were 
greater than 2 and peak purity index values were close 
to 1 as shown at Table 1, thus it can be concluded that 
the method is specific. 
 
3.3. Precision 
ICH defines the precision of an analytical procedure 
as the closeness of agreement  between a series of 
measurements obtained from multiple sampling of the 
same homogeneous sample under the prescribed 
conditions.   The aim   of   repeatability   test is determine  
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ability of the method to analyze samples at the same 
operational conditions within a short time. Repeatibility 
should be assed using a minimum 9 determination 
covering the specified range for the procedure or a 
minimum of 6 determination at 100% of the test 
concentration.  
Repeatibility test on this study done by 
determination 5 concentrations on 3 replicates each, and 
expressed by %RSD. The precision result shown at table 
2. RSD concetration  of MET, B1 and B6 at each 
concentration were lower than 2%, so it can be 
concluded that the analytical method was precision. 
3.4. Accuracy 
Accuracy is a parameter to indicate the closeness 
between the values obtained with the true value, 
expressed in percent recovery. ICH recommends that 
the accuracy was done by 9 times assay at 3 different 
concentrations. In this study the accuracy performed at 
5 concentrations by spiking method, namely by adding a 
certain amount of the standard solution to the sample 
solution from stock (2.3.3) with a ratio of 3 : 7.  
The accuracy result shown at table 2. Recovery of 
MET, B1 and B6 were in the range of 98-102%, which 
means that the method has good accuracy. 
 
Fig 2. Chromatogram of the mixture of pyridoxine (Rt = 4.81), metamizole (Rt = 9.82) and Thiamine (Rt = 14.69). HPLC condition : 
coloumn: Waters, Atlantis T3, C-18, 150 x 4.6 mm, 5 µm; mobile phase : PIC solution : methanol : Acetic acid (700 : 300 : 4 
v/v/v); flow rate : 1.2 mL/minute ; injection volume 20 µL ; detector 275 nm 
 
Table 1. performance parameters of Metamizole, Thiamin (B1) and Pyridoxin (B6) in system suitability test 
 
  Retention time Peak Area Resolution Peak purity index 
Compound Mean (n=6) RSD (%) Mean (n=6) CV (%) Mean (n=6) 
B6 4.81 0,89 822432 0.06 13,90 1.000 
MET 9.82 1.17 3188671 0.95 14.99 0.999 
B1 14.69 1.54 496160 0.14 10.15 0.999 
  
         Table 2. Precision and Accuration result 
 % Recovery (n=3, mean) ± % RSD 
Conc (μg/mL) B6 MET B1 
260 99.31± 0.05 98.43 ± 0.57 98.84 ± 0.52 
230 99.45 ± 0.05 98.60 ± 0.44 99.41 ± 1.31 
200 99.39 ± 0.10 98.44 ± 0.41 99.32 ± 0.97 
170 99.60 ± 0.05 98.64 ± 0.58 99.39 ± 0.97 
140 99.43 ± 0.65 98.27 ± 0.29 99.44 ± 1.16 
 
        Tabel 3.  Linearity results 
 
Compound Equation r 
Metamizol Y = 232,513.69 x + 2,672.38 0.9998 
Thiamine Y = 466,939.20 x + 4,092.21 0.9992 
Pyridoxin Y = 232,513.69 x – 2,672.39 0.9998 
 
Table 4. The level of Metamizole (MET), Thiamin (B1) and Pyridoxine (B6) of tablet dosage form obtained by HPLC and by uv 
spectrophotometry in combination with PLS  
 
Compound 
Concentration mg/tab (mean,n=6) ± %RSD 
HPLC Uv-PLS 
B6 98.96 ± 0.67 98.44 ± 1.66 
MET 480.32 ± 0.76 482.15 ± 0.38 
B1 49.68 ± 1.56 50.24 ±1.82 
 




Linearity test conducted by injecting 5 series 
concentrations in the range 70-130% of the target 
concentration with 3 times replication. The response 
should be directly proportional to the concentrations of 
the analytes or proportional by means of a well-defined 
mathematical calculation.The linearity result shown at 
table 3.  
The linearity result  of MET, B1 and B6 showed that 
coefficient correlation (r) greater than 0.999, so it can be 
stated that the method produces peak area that is 
proportional to the analyte concentration. 
3.6. Samples analysis using HPLC 
The results of determination MET, B1 and B6 in 
tablet dosage form shown in the table 4, and when 
compared with the result of spectrophotometric 
method combined multivariate calibration patial least 
square (PLS) are not significantly different. Thus it can 
be concluded that both methods can be used to 
determination MET, B1 and B6 with precision and 
accuracy as good. 
 
4. Conclusion 
The simultaneous determination of  metamizol, 
thiamine and pyridoxin was performed on a C18 column 
of (4.6x150mm) dimension and 5 μm of particle size. A 
mixture of PIC : Methanol : acetic acid (700 : 300 : 4) 
(v/v/v) as mobile phase with flow rate of 1.2 mL/minute 
and monitored at 275 nm. That method was simple, 
accurate, precise, and could be successfully applied for 
the analysis of metamizol, thiamine and pyridoxin in 
multicomponent tablet dosage form. 
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